Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Center, Open-Label, Dose-Escalation Phase I Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for Diabetic Nephropathy

NCT07822152 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT07822152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07822152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Center, Open-Label, Dose-Escalation Phase I Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for Diabetic Nephropathy
Lead sponsor
Tongji Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
March 25, 2026
Completion date
March 25, 2028
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic nephropathy